The results, published in Journal of Heart and Lung Transplantation, implanted the Jarvik 2015 Ventricular Assist Device in seven children ages 8 months to 7 years. The children spent months using the device before their transplant and were able to participate in normal play activities. All the children survived, though one child — whose heart recovered and thus did not require a transplant — had a stroke on the 53rd day following device implantation.
The device is not FDA approved.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
